Hims & Hers Health, Inc.

Filing Date

Aug 20, 2025

Transaction Date

Aug 18, 2025

Accession Number

0001773751-25-000280

Form Type

4

Net Trading Amount

-$7.9M

Footnotes

1. (F1)The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
2. (F2)Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.76 - $45.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3. (F3)Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.85 - $45.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
4. (F4)Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.95 - $45.39. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
5. (F5)Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.68 - $45.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
6. (F6)Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.69 - $45.40. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
7. (F7)Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.65 - $45.35. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
8. (F8)This amount reflects an annuity payment-in-kind of 26,461 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.
9. (F9)This amount reflects an annuity payment-in-kind of 26,461 shares of Class A Common Stock from the AD 2022 GRAT to the Andrew Dudum 2015 Trust dated July 2, 2015.
10. (F10)Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.
11. (F11)The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.